Top 50 Health & Wellness Trends (October 2026)

Health and Wellness in 2026: People Are Searching by Name

The health trends of 2026 have one thing in common: the biggest rising searches name the exact drug, test, compound or condition rather than a general goal. The biggest health search in our table is a molecule, "tirzepatide", at 1,220,000 monthly searches as of August 2026. Right behind it sits "peptide" at 1,000,000 searches, up +232% year over year.

This page groups those rows into six wellness trends for 2026: the GLP-1 shift from injections to pills, the self-sourced compound shelf, the scans and biomarkers people order for themselves, the conditions people are learning to name, the outbreaks that drive sudden spikes, and the everyday care that has moved into the home.

Monthly searches are search volume as of August 2026. Growth compares August 2026 with August 2025.

We rebuilt this list on October 12, 2026 from our live trend database, the same feed that powers the table above. The headline is a shift in format rather than in subject. Brand-name GLP-1 searches are flat or falling, with "ozempic" down -45% over the year, while "glp 1 pills" is up +172%. Outbreak names had the sharpest single moves of the summer, led by "cyclosporiasis", a breakout from almost no searches a year ago. Two of the largest rows are conditions, "disease pots" and "postpartum psychosis", which tells you how much of health search is now people looking for a name for what they feel.

---

1. GLP-1 Drugs Move From the Brand to the Molecule and the Pill

GLP-1 medicines are still the largest health story in search, but the shape of the demand changed this year. "Tirzepatide", the active ingredient rather than a brand, leads the table at 1,220,000 monthly searches as of August 2026, up +22% year over year and flat over the past three months. The brand names around it are cooling. "Zepbound" holds at 823,000 searches with no annual growth, "mounjaro" is down -18% at 673,000, and "ozempic" has fallen -45% to 450,000. "Semaglutide" is down -33% at 301,000 searches.

The growth has moved to format. "Glp 1 pills" is up +172% at 201,000 searches, and "weight loss pills" is up +22% at 110,000. The brand "wegovy pill" shows the launch pattern clearly: it grew about 125x over the year to 301,000 searches, then dropped -45% over the past six months once the first wave of curiosity passed. Further out, "glp 3" is up +512% at 74,000 searches, a sign that people already look past the current drugs to the next generation of research compounds.

The metabolic vocabulary is spreading with it. "Insulin resistance" is up +23% at 135,000 searches. Our deep dive on one compounded tirzepatide brand shows how fast a single telehealth name can grow inside this market.

Why the GLP-1 Market Is Shifting

Search interest is moving because:

• Molecule literacy: People search the active ingredient, which covers brand, compounded and research versions at once
• Pill formats: Oral versions remove the needle, and searches for them grew faster than any injection brand
• Price shopping: Searching by molecule is how people compare cash prices across pharmacies and telehealth
• Next-generation curiosity: Terms like glp 3 show interest in drugs that are still in research

What's Gaining Momentum

Tirzepatide (1,220,000 searches, +22% YoY): The largest health search in the table, and the clearest case of people searching the molecule instead of the brand.

GLP 1 Pills (201,000 searches, +172% YoY): Oral formats are the fastest-growing part of the GLP-1 conversation.

Peptides Weight Loss (165,000 searches, +173% YoY): A bridge term that links the GLP-1 story to the wider peptide market in the next section.

Insulin Resistance (135,000 searches, +23% YoY): The metabolic condition people now look up next to weight-loss drugs.

Weight Loss Pills (110,000 searches, +22% YoY): A broad term that rose with the oral launches, then eased.

GLP 3 (74,000 searches, +512% YoY): Interest in the next class of research compounds, ahead of any approval.

Key Players

• Eli Lilly: Maker of tirzepatide, sold as Zepbound and Mounjaro
• Novo Nordisk: Maker of semaglutide, sold as Ozempic and Wegovy, including the Wegovy pill
• Hims: Telehealth brand with a weight-loss program, at 368,000 searches and down -18% over the year

---

2. Peptides and the Self-Sourced Compound Shelf

The fastest-growing large term on this page is a whole category. "Peptide" is up +232% year over year at 1,000,000 monthly searches as of August 2026, although it slipped -18% over the past three months. Our full report on the peptide trend maps where that demand goes.

The most telling row is not a peptide at all. "Bacteriostatic water", the sterile water used to mix powdered injectables, is up +232% at 246,000 searches, the same annual growth as peptide itself. When the supply term grows in step with the product term, it suggests that some searchers are preparing compounds at home. We report the pattern only.

Other compounds are following the same path from niche forums to mainstream search. "Astaxanthin", a red pigment from algae sold as a supplement, is up +307% at 301,000 searches. "Dmso", an industrial solvent with a long history in alternative health circles, is up +22% at 110,000. "Palo azul", an herbal tea marketed for detox, is up +83% at 60,500 searches, and "creatine for women" is up +22% at 60,500. For more on the supplement side of this shelf, see our supplement trends page.

Why Self-Sourced Compounds Are Rising

This cluster is growing because:

• Online availability: Compounds that once needed a clinic are now sold directly, often labeled for research only
• Social video: Short clips about peptides, astaxanthin and DMSO spread long before any clinical review
• Do-it-yourself prep: Supply terms like bacteriostatic water rise in step with the compounds they are used with

What's Gaining Momentum

Peptide (1,000,000 searches, +232% YoY): The second-largest term in the table and the umbrella over much of this section.

Astaxanthin (301,000 searches, +307% YoY): An algae-derived pigment marketed for skin and healthy aging, with growth that picked up again over the past three months.

Bacteriostatic Water (246,000 searches, +232% YoY): A supply term whose growth matches the peptide curve almost exactly.

DMSO (110,000 searches, +22% YoY): A solvent that keeps returning to wellness search, with steady growth over three, six and twelve months.

Palo Azul (60,500 searches, +83% YoY): An herbal tea marketed for detox, rising on social video.

Creatine for Women (60,500 searches, +22% YoY): A gym supplement finding a new audience through women's strength training content.

---

3. Scans, Biomarkers and the Treatment Pipeline

A growing share of health search is about measuring the body before anything feels wrong. "Fatty liver disease" is up +123% year over year at 301,000 monthly searches as of August 2026, and it grew just as fast over the past three months. Its companion term "fatty liver treatment" is up +172% at 110,000 searches.

Self-ordered tests are the other half of this story. "Dexa scans", the body-composition scans that measure bone, fat and muscle, are up +49% at 201,000 searches. "Apolipoprotein b", a cholesterol-related blood marker, is up +122% at 110,000. "Sarcopenia", the age-related loss of muscle that a DEXA scan can show, is up +22% at 90,500 searches. The big lab brands sit underneath all of it: "quest diagnostics" and "labcorp" each draw 4,090,000 searches, flat over the year, because they are where many of these tests get done.

The research pipeline is reaching search too. "Cancer vaccine" is up +309% at 74,000 searches, with most of that growth in the past three months. "Daraxonrasib", an experimental pancreatic cancer drug in clinical trials, grew about 57x over the year to 90,500 searches. A search is not evidence that a treatment is available or effective. "Sickle cell disease" is up +49% at 74,000, though it has fallen back over the past six months.

Why Diagnostics Are Rising

People are searching scans and markers more because:

• Direct-to-consumer testing: Blood panels and body scans can now be booked without a referral in many places
• Longevity content: Podcasts and creators talk about markers like apolipoprotein b by name
• Incidental findings: Fatty liver often appears on tests ordered for something else, prompting follow-up searches
• Trial news: Cancer vaccine and daraxonrasib headlines send people to search the drug name directly

What's Gaining Momentum

Fatty Liver Disease (301,000 searches, +123% YoY): The largest diagnostic term on the page, growing at the same pace over three months as over twelve.

Dexa Scans (201,000 searches, +49% YoY): Body-composition scans are moving from sports science into general wellness search.

Fatty Liver Treatment (110,000 searches, +172% YoY): The follow-up search that rises after a diagnosis.

Apolipoprotein B (110,000 searches, +122% YoY): A blood marker people now look up by name.

Daraxonrasib (90,500 searches): A breakout drug name, about 57x higher than a year ago, driven by trial coverage.

Cancer Vaccine (74,000 searches, +309% YoY): Therapeutic vaccine research in general search, with the sharpest move in the past three months.

Key Players

• Quest Diagnostics: National lab network, at 4,090,000 searches a month
• Labcorp: The other national lab network, also at 4,090,000 searches
• Revolution Medicines: The biotech company developing daraxonrasib

---

4. Conditions People Are Learning to Name

Some of the largest risers on this page are not products at all. They are diagnoses people search when they are trying to put a name to symptoms. "Disease pots", the search for postural orthostatic tachycardia syndrome, sits at 673,000 monthly searches as of August 2026, up +22% year over year. POTS causes dizziness and a racing heart on standing.

The steepest climb in this group is "postpartum psychosis", up about 16.6x over the year to 368,000 searches and still up +397% over the past three months. Postpartum psychosis is a rare psychiatric emergency after childbirth, and sudden spikes for rare conditions often follow news coverage. It is a crisis term, not a wellness trend, and we include it only because it is in the data. Nearby, "pmdd", premenstrual dysphoric disorder, is up +22% at 301,000 searches, and "perimenopause" holds at 368,000 with +22% growth over the past six months.

Neurological and immune conditions round out the group. "Cte", chronic traumatic encephalopathy, is up +22% at 246,000 searches and +49% over the past three months. "Prion disease" is up +83% at 201,000. "Mcas symptoms", the search for mast cell activation syndrome, is up +83% at 90,500, and "dyspraxia", a coordination disorder, is up +49% at 110,000. For the mental health side of this picture, see our mental health trends page.

Why Condition Searches Are Rising

These searches are growing because:

• Patient communities: People with POTS, MCAS and PMDD share their experience online, and the names travel with it
• Adult diagnosis: Many adults now look into conditions like dyspraxia that were missed in childhood
• News cycles: Single stories can multiply searches for rare conditions like postpartum psychosis or prion disease
• Women's health focus: Perimenopause and PMDD get more attention from clinicians, telehealth brands and creators

What's Gaining Momentum

Disease POTS (673,000 searches, +22% YoY): The largest condition search in the table, built by patient communities online.

Postpartum Psychosis (368,000 searches, 16.6x YoY): A rare emergency whose search spike follows news coverage, not a trend to act on.

PMDD (301,000 searches, +22% YoY): A severe premenstrual condition that more people now search by its acronym.

CTE (246,000 searches, +22% YoY): Brain injury research tied to contact sports, with faster growth over the past three months.

Prion Disease (201,000 searches, +83% YoY): Rare misfolded-protein illness drawing more attention over the year.

MCAS Symptoms (90,500 searches, +83% YoY): A symptom-led search for an immune condition that is often hard to diagnose.

Key Players

• Midi Health: Telehealth clinic focused on perimenopause and menopause care, at 201,000 searches and up +83% over the year

---

5. Outbreaks, Bites and the Summer Spike

The sharpest moves in health search follow the news, and this summer had plenty of it. "Cyclosporiasis", an intestinal infection from a parasite usually spread through contaminated fresh produce, pulled 823,000 monthly searches as of August 2026. A year earlier it barely registered, which makes it a breakout rather than a steady riser.

Respiratory and food-borne illness followed the same calendar. "Summer covid surge" is also a breakout, at 110,000 searches from almost nothing a year ago. "Listeria" is up +49% at 135,000, and +82% over the past three months alone. "N95 mask" is up +22% at 74,000 searches, though it has dropped -33% over the past three months as the summer wave eased.

Bites and mosquito-borne disease are a growing seasonal block. "Lone star tick", the tick linked to a red meat allergy, is up +122% year over year at 201,000 searches, but it fell -80% over the past three months as tick season ended. "West nile virus" sits at 301,000 searches, flat over the year but about 13.6x higher than six months ago. "Dengue fever" is up +49% at 135,000. And one slang term has gone mainstream: "scromiting", the informal name for cannabis hyperemesis syndrome, grew about 57x over the year to 90,500 searches.

Why Outbreak Searches Spike

This cluster moves the way it does because:

• Recall cycles: Food-borne outbreaks like cyclosporiasis and listeria peak with each public recall notice
• Seasonal vectors: Ticks and mosquitoes arrive on a schedule, and so do the searches about them
• Covid waves: Summer surges bring back mask and symptom searches for a few weeks at a time

What's Gaining Momentum

Cyclosporiasis (823,000 searches, breakout): A produce-linked parasite infection and the biggest outbreak term of the summer.

Lone Star Tick (201,000 searches, +122% YoY): Tick identification and allergy searches that rise sharply in warm months, then drop away.

Listeria (135,000 searches, +49% YoY): Food-borne illness searches that climb with every recall.

Dengue Fever (135,000 searches, +49% YoY): A mosquito-borne illness searched more as its range widens, up +173% over the past three months.

Summer Covid Surge (110,000 searches, breakout): The seasonal covid wave, searched by name for the first time at this scale.

Scromiting (90,500 searches, 57x YoY): A slang term for a cannabis-related vomiting syndrome that has crossed into mainstream search.

Key Players

• CDC: Publishes outbreak notices and the tick and mosquito guidance these searches land on
• FDA: Issues the food recall notices behind listeria and cyclosporiasis spikes

---

6. Everyday Care Moves to the Pharmacy Aisle and the Home

The last group is the least dramatic and the most durable. "Eye drop" is up +172% year over year at 201,000 monthly searches as of August 2026, with the same growth over the past three months. "Eye patches" is up +82% at 110,000, and "saline nasal spray" is up +83% at 90,500. The broad search "over the counter" is up +309% at 74,000 searches, a sign that people shop pharmacy products by category, not only by brand.

Skin and hair care with a medical flavor are climbing too. "Eczema treatment" sits at 201,000 searches, up +22% over the year, though it fell back -63% over the past three months after a strong spring. "Hypochlorous acid", a mild antimicrobial spray sold for skin, is up +22% at 110,000. "Tranexamic acid" is up +23% at 135,000, "urea cream" is up +49% at 74,000, and "hair loss" is up +233% at 74,000 searches. Mouth care is on the same path, with "hydroxyapatite toothpaste" and "best electric toothbrush" each at 74,000 searches, up +22%. The skincare angle has its own page on our skincare trends page.

Care itself is moving home. "In-home senior care" grew about 13.6x over the year to 201,000 searches and is still up +396% over the past three months. "Urgent care kit" is up +83% at 60,500, and "gut health" is up +49% at 60,500, with +123% growth over the past three months. Pharmacy brands still carry the largest volumes: "cvs" draws 20,400,000 searches and "walgreens pharmacy" draws 3,350,000, both flat over the year, while "fsa store" is up +49% at 246,000 as people look for ways to spend pre-tax health money on these products.

Why Everyday Care Is Growing

This cluster is rising because:

• Self-care first: People try the pharmacy aisle before booking an appointment
• Ingredient shopping: Searches name actives like hypochlorous acid, urea and hydroxyapatite instead of brands
• Aging at home: Families look for in-home senior care as an alternative to facilities
• Pre-tax spending: FSA and HSA accounts push people to search what counts as an eligible health product

What's Gaining Momentum

Eye Drop (201,000 searches, +172% YoY): The biggest pharmacy-aisle riser on the page, still accelerating.

In-Home Senior Care (201,000 searches, 13.6x YoY): Families searching for help at home, the fastest-growing care search on the page.

Eczema Treatment (201,000 searches, +22% YoY): A skin search that rose sharply over six months, then cooled over the past three.

Hypochlorous Acid (110,000 searches, +22% YoY): A gentle antimicrobial spray that moved from clinics into skincare routines.

Saline Nasal Spray (90,500 searches, +83% YoY): A simple pharmacy staple with strong annual growth.

Hair Loss (74,000 searches, +233% YoY): A broad search that has more than tripled in a year.

Key Players

• CVS: The largest pharmacy brand in the data, at 20,400,000 searches a month
• FSA Store: Retailer of FSA-eligible products, at 246,000 searches and up +49% over the year

---

If you want to explore more trends, sign up for free and unlock the full experience.

---

Summary

Health and wellness search in 2026 is specific. People search the molecule, the marker, the acronym and the outbreak by name. Tirzepatide (1,220,000 searches, +22%) and peptide (1,000,000 searches, +232%) lead the table, while the older GLP-1 brand names cool and pill formats take the growth. Around them, conditions like disease pots (673,000 searches) and outbreak names like cyclosporiasis (823,000 searches, breakout) show how much of health search is people trying to understand something that just happened to them.

The main takeaways from this data:

• Molecules over brands: GLP-1 demand has moved to the ingredient name and to pills, while Ozempic searches fell -45% in a year
• A self-sourced shelf: Peptide and bacteriostatic water both grew +232%, a sign of compounds bought and prepared outside the clinic
• Measuring before treating: Fatty liver disease, DEXA scans and apolipoprotein b all grew as people order their own tests
• Names for symptoms: POTS, PMDD, MCAS and CTE are searched as acronyms, driven by patient communities and news
• Care at home: In-home senior care grew about 13.6x and pharmacy-aisle products like eye drops grew +172%

For brands, publishers and health teams, the opportunity is clear, accurate information at the moment someone first searches a name. See how Rising Trends helps you track market shifts across health and every other category.